SHL Medical is pleased to announce the release of its 2023 sustainability report
Menu
The Science Based Targets initiative (SBTi) has approved SHL Medical’s near-term science-based emissions reduction target, underlining the company’s dedication to remaining transparent and accountable throughout its entire sustainability journey.
The Science Based Targets initiative (SBTi) has approved SHL Medical’s near-term science-based emissions reduction target, underlining the company’s dedication to remaining transparent and accountable throughout its entire sustainability journey.
The Alliance Management program will further strengthen SHL Medical’s vertically integrated business model by facilitating customer engagement with other key players within the drug delivery ecosystem.
SHL Medical AG reinforces its commitment to sustainability and responsible corporate governance by officially joining the United Nations Global Compact (UNGC).
SHL Medical announced today the release of its Sustainability Report for 2022. The report provides a comprehensive overview of the company’s efforts to promote sustainability and outlines its commitment to a sustainable future.
To support the victims of the earthquake in Türkiye and Syria, SHL Medical has donated a total of US$100,000 to the UNHCR and Doctors Without Borders/Médecins Sans Frontières.
To support the development of rapidly implementable and holistic approaches to CO2 reduction in the industrial environment, SHL Medical has joined the “Association for the Decarbonization of Industries”. The recently founded association focuses on new hydrogen production processes for the decarbonization of industrial high-temperature processes and logistics.
SHL Medical has paired up with the CPhI Podcast series to present the “Leveraging data science for sustainable autoinjector development” podcast, featuring ESG Project Manager Veluska Bruce and Senior Manager of Data Science Frederick Gertz.
